降钙素原对指导慢性阻塞性肺疾病急性加重期抗生素使用的意义(3)
![]() |
第1页 |
参见附件。
[3]中华医学会呼吸病学分会慢性阻塞肺疾病分组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.
[4]降钙素原急诊临床应用专家共识组.PCT急诊临床应用的专家共识[J].中华急诊医学杂志,2012,21(9):944-951.
[5]周庆涛,姚婉贞,陈哑红,等.慢性呼吸道疾病并发社区获得性下呼吸道感染住院患者的病原菌调查[J].中国呼吸与危重监护杂志,2007,6(2):82-87.
[6]张金松,茅敏华,姜觉如.AECOPD病原菌分布及耐药性分析[J].临床肺科杂志,2011,16(5):695-696.
[7] Tasdelen F N,Aliyazicioglu Y,Coban Y,et al. The value of neopterin and procalcitonin in patients with sepsis[J].South Medcine,2010,103(3): 216-219.
[8] Beeker K L,StIider R,Nylen E S.Procalcitonin assay in systemic inflammation,infection,and sepsis:clinical atility and limitations[J].Crit Care Med,2008,36(6):941-952.
[9] Christ-Crain M,Stolz D,Bingisser R,et al. Procalcitonin guidance of antibiotic therapy in community--acquired pneumonia:a randomized trial[J]. Am J Respir Crit Care Med,2006,174(1): 84-93.
[10] Lee M,Snyder A.The role of procalcitonin in commmunity-acquied pneumonia[J].Advanced Emergency Nursing Journal,2012,34(3):259-271.
[11] Rothberg M B,Pekow P S,Lahti M,et al. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease[J].JAMA,2010,303(20):2035-2042.
(收稿日期:2014-03-01) (编辑:韩珊珊)
您现在查看是摘要介绍页,详见PDF附件。